Your browser doesn't support javascript.
loading
Real-world treatment patterns and clinical outcomes with first-line therapy in patients with locally advanced/metastatic urothelial carcinoma by cisplatin-eligibility.
Morgans, Alicia K; Galsky, Matthew D; Wright, Phoebe; Hepp, Zsolt; Chang, Nancy; Willmon, Candice L; Sesterhenn, Steve; Liu, Yutong; Sonpavde, Guru P.
Afiliación
  • Morgans AK; Dana-Farber Cancer Institute, Boston, MA. Electronic address: aliciak_morgans@dfci.harvard.edu.
  • Galsky MD; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
  • Wright P; Seagen Inc., Bothell, WA.
  • Hepp Z; Seagen Inc., Bothell, WA.
  • Chang N; Seagen Inc., Bothell, WA.
  • Willmon CL; Seagen Inc., Bothell, WA.
  • Sesterhenn S; Astellas Pharma Inc., Northbrook, IL.
  • Liu Y; Genesis Research, Hoboken, NJ.
  • Sonpavde GP; Dana-Farber Cancer Institute, Boston, MA; AdventHealth Cancer Institute and University of Central Florida, Orlando, FL.
Urol Oncol ; 41(8): 357.e11-357.e21, 2023 08.
Article en En | MEDLINE | ID: mdl-37208230

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Vejiga Urinaria / Carcinoma de Células Transicionales / Neoplasias Urológicas Tipo de estudio: Observational_studies Idioma: En Revista: Urol Oncol Asunto de la revista: NEOPLASIAS / UROLOGIA Año: 2023 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Vejiga Urinaria / Carcinoma de Células Transicionales / Neoplasias Urológicas Tipo de estudio: Observational_studies Idioma: En Revista: Urol Oncol Asunto de la revista: NEOPLASIAS / UROLOGIA Año: 2023 Tipo del documento: Article